Sex Disparity in Adult Asthma-A Potential Immunomodulatory Role of Let-7 Family MicroRNAs

Overview

Journal Clin Transl Allergy

Publisher Wiley

Specialty Allergy & Immunology

Date 2025 Mar 1

PMID 40022441

Authors

Carina Malmhall

Jenny Calven

Julie Weidner

Kristina Johansson

Patricia Ramos-Ramirez

Emma Boberg

Linda Ekerljung

Roxana Mincheva

Bright Nwaru

Hannu Kankaanranta

Henric Olsson

Christopher McCrae

Madeleine Radinger

Affiliations

Soon will be listed here.

Abstract

Background: Sex differences have been reported in the incidence, prevalence and severity of asthma. Previous findings from animal models have revealed sex-related differences in inflammatory pathways that may contribute to asthma pathogenesis, but human studies are limited.

Methods: Airway and blood samples (n = 55 and n = 85 respectively) were collected from adult females and males with asthma and healthy subjects. Type 2 innate lymphoid cells (ILC2s), T helper (Th)2 cells and their expression of IL-33R/ST2 (ST2L) were evaluated by flow cytometry. IL-13, thymic stromal lymphopoietin (TSLP), IL-33 and soluble IL-33R/ST2 (sST2) were measured by ELISA. Let-7 miRNA expression in bronchial biopsies was determined by qPCR.

Results: Females with asthma reported more exacerbations and had a higher number of airway eosinophils compared with males with asthma. Bronchial biopsy expression of Let-7f, Let-7g and miR-98 tended to be higher in males with asthma compared with females and inversely correlated with asthma exacerbations. In contrast, increased levels of IL-13, TSLP and sST2 were found in females with asthma compared with males.

Conclusion: Our study demonstrates different inflammatory signatures between males and females with asthma. Let-7 miRNAs act as immune modulators by inhibiting the production of IL-13 and may be an important factor explaining the sex disparity seen in asthma.

References

Bartemes K, Chen C, Iijima K, Drake L, Kita H . IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus. J Immunol. 2017; 200(1):229-236. PMC: 5736420. DOI: 10.4049/jimmunol.1602085. View

Leffler J, Stumbles P, Strickland D . Immunological Processes Driving IgE Sensitisation and Disease Development in Males and Females. Int J Mol Sci. 2018; 19(6). PMC: 6032271. DOI: 10.3390/ijms19061554. View

Winkler C, Hochdorfer T, Israelsson E, Hasselberg A, Cavallin A, Thorn K . Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients. J Allergy Clin Immunol. 2019; 144(1):61-69.e7. DOI: 10.1016/j.jaci.2019.01.027. View

Zhang G, Ozuygur Ermis S, Radinger M, Bossios A, Kankaanranta H, Nwaru B . Sex Disparities in Asthma Development and Clinical Outcomes: Implications for Treatment Strategies. J Asthma Allergy. 2022; 15:231-247. PMC: 8863331. DOI: 10.2147/JAA.S282667. View

Aw M, Nair P, Salter B, Chen R, Machida K, Inman M . Effect of sex on group 2 innate lymphoid cells in the airways of mild and severe asthmatics. Allergy. 2019; 74(7):1397-1400. DOI: 10.1111/all.13742. View

Mehrabi Nasab E, Makoei R, Aghajani H, Athari S . IL-33/ST2 pathway as upper-hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure. ESC Heart Fail. 2022; 9(6):3785-3790. PMC: 9773709. DOI: 10.1002/ehf2.14111. View

Du J, Wu H, Wu Y . MiR-98-5p may be a Biomarker for Screening Bronchial Asthma in Children by Targeting IL-13. Clin Lab. 2019; 65(3). DOI: 10.7754/Clin.Lab.2018.180834. View

Laffont S, Blanquart E, Savignac M, Cenac C, Laverny G, Metzger D . Androgen signaling negatively controls group 2 innate lymphoid cells. J Exp Med. 2017; 214(6):1581-1592. PMC: 5461006. DOI: 10.1084/jem.20161807. View

Parnes J, Molfino N, Colice G, Martin U, Corren J, Menzies-Gow A . Targeting TSLP in Asthma. J Asthma Allergy. 2022; 15:749-765. PMC: 9172920. DOI: 10.2147/JAA.S275039. View

10.

Porsbjerg C, Melen E, Lehtimaki L, Shaw D . Asthma. Lancet. 2023; 401(10379):858-873. DOI: 10.1016/S0140-6736(22)02125-0. View

11.

Malmhall C, Weidner J, Radinger M . MicroRNA-155 expression suggests a sex disparity in innate lymphoid cells at the single-cell level. Cell Mol Immunol. 2019; 17(5):544-546. PMC: 7193614. DOI: 10.1038/s41423-019-0303-4. View

12.

Christianson C, Goplen N, Zafar I, Irvin C, Good Jr J, Rollins D . Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol. 2015; 136(1):59-68.e14. PMC: 4494983. DOI: 10.1016/j.jaci.2014.11.037. View

13.

Smith S, Chen R, Kjarsgaard M, Huang C, Oliveria J, OByrne P . Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol. 2015; 137(1):75-86.e8. DOI: 10.1016/j.jaci.2015.05.037. View

14.

Bielska A, Skwarska A, Kretowski A, Niemira M . The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases. Int J Mol Sci. 2022; 23(3). PMC: 8835816. DOI: 10.3390/ijms23031553. View

15.

Canas J, Rodrigo-Munoz J, Sastre B, Gil-Martinez M, Redondo N, Del Pozo V . MicroRNAs as Potential Regulators of Immune Response Networks in Asthma and Chronic Obstructive Pulmonary Disease. Front Immunol. 2021; 11:608666. PMC: 7819856. DOI: 10.3389/fimmu.2020.608666. View

16.

Collison A, Mattes J, Plank M, Foster P . Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol. 2011; 128(1):160-167.e4. DOI: 10.1016/j.jaci.2011.04.005. View

17.

Jacquelot N, Luong K, Seillet C . Physiological Regulation of Innate Lymphoid Cells. Front Immunol. 2019; 10:405. PMC: 6422966. DOI: 10.3389/fimmu.2019.00405. View

18.

Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A, Agrawal A . Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol. 2011; 128(5):1077-85.e1-10. DOI: 10.1016/j.jaci.2011.04.034. View

19.

. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

20.

Nwaru B, Ekerljung L, Radinger M, Bjerg A, Mincheva R, Malmhall C . Cohort profile: the West Sweden Asthma Study (WSAS): a multidisciplinary population-based longitudinal study of asthma, allergy and respiratory conditions in adults. BMJ Open. 2019; 9(6):e027808. PMC: 6589027. DOI: 10.1136/bmjopen-2018-027808. View